MLchartDataset catalogue

Batimastat

Term · Oncology and biomedicine · MLC-T-ONC-000930

An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. Batimastat is a matrix metalloproteinase inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-000930
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000930",
  "term": "Batimastat",
  "field": "Oncology and biomedicine",
  "definition": "An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors. Batimastat is a matrix metalloproteinase inhibitor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/batimastat/"
}

Record 3,307 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.